Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps
Pathology and Oncology Research · 18.04.2023 · 29
DOI: 10.3389/pore.2023.1610899 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology and Oncology Research, online erschienen am 18.04.2023. Verfasst von Yanhua Zuo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Extracellular Traps, RNA, Long Noncoding, MicroRNAs, Adenocarcinoma. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Neutrophil Extracellular Traps (NETs) are fibrous networks made of DNA-histone complexes and proteins protruded from activated neutrophils. Accumulating evidences have highlighted the vital role of NETs in tumor progression and diffusion. However, limited systematic studies regarding the role of NETs in LUAD have been performed.
Methods
Differentially expressed NETs-related genes and their mutation landscape were identified with TCGA database. Consensus clustering analysis was performed to determine the NETs-related subtypes of LUAD. LASSO algorithm was employed to construct a prognostic signature. Moreover, GSE30219 and GSE31210 were used as independent validation. We also constructed a lncRNA-miRNA-mRNA regulatory axis with several miRNA and lncRNA databases.
Results
Consensus clustering identified two NETs-related clusters in LUAD. High NETs score was correlated with a favorable overall survival, abundant immune cell infiltration, and high activity of immune response signal pathways. Six NET-related genes (G0S2, KCNJ15, S100A12, AKT2, CTSG, and HMGB1) with significant prognostic value were screened to develop a prognostic signature. LUAD patients with low-risk had a significantly favorable overall survival both in the training set and validation set. Moreover, NETs-related risk score and clinical stage could act as an independent prognostic factor for LUAD patients. Significant correlation was obtained between risk score and tumor immune microenvironment. We also identified lncRNA BCYRN1/miR-3664-5p/CTSG regulatory axis that may be involved in the progression of LUAD.
Conclusion
We developed two molecular subtypes and a prognostic signature for LUAD based on NETs-related genes. This stratification could provide more evidences for estimating the prognosis and immunotherapy of LAUD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, China.
- Laboratory of Drug Metabolism and Pharmacokinetics, Shenyang Pharmaceutical University, Shenyang, China.
Zitieren
APA
Zuo, Y., Leng, G., & Leng, P. (2023). Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps. Pathology and Oncology Research, 29. https://doi.org/10.3389/pore.2023.1610899
Vancouver
Zuo Y, Leng G, Leng P. Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps. Pathology and Oncology Research. 2023;29. doi:10.3389/pore.2023.1610899
BibTeX
@article{Zuo2023,
author = {Zuo, Yanhua and Leng, Guangyi and Leng, Ping},
title = {Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps},
journal = {Pathology and Oncology Research},
year = {2023},
volume = {29},
doi = {10.3389/pore.2023.1610899}
}
EUVIMED